Women's health and digital radiography specialist Hologic achieved an 8% rise in revenues during the second quarter ended March 29, racking up $50.3 million compared with $46.4 million over the same period a year earlier. Net income was down markedly,
Women's health and digital radiography specialist Hologic achieved an 8% rise in revenues during the second quarter ended March 29, racking up $50.3 million compared with $46.4 million over the same period a year earlier. Net income was down markedly, however: $383,000 compared with $4.43 million in 2Q 2002. The earlier results reflected a $4.4 million tax refund from the Bush administration's Economic Stimulus Bill. Pretax income increased to $435,000 from $3000 in the second quarter FY 2002. The company achieved this improvement despite the increased investment in sales and service in connection with its transition to a direct sales and service organization for mammography products.
During the second quarter, Hologic shipped 14 Selenia full-field digital mammography systems. Eleven were recognized in revenue during the quarter. At the end of March 2003, the company had a backlog of 40 Selenia orders. On April 24, the firm announced the launch of Selenia sales in the U.K.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.